WAUPACA, Wis. – Wisconsin's annual gun deer hunting season is over, and preliminary figures from the Department of Natural Resources show more than 140,000 deer were taken, about 3,500 fewer than last year.

This year's estimate for percentage of the herd infected with chronic wasting disease (CWD) is not yet in, but last year it hit a record of 9.4 percent of deer tested.

The Wisconsin Division of Public Health says venison from deer taken in one of the many CWD zones in the state should not be eaten until it is tested and the results are negative.

Lifelong outdoorsman Pat Durkin, president of the Wisconsin Outdoor Communicators Association, says the DNR is downplaying the danger CWD poses.

"I don't think Wisconsin has come anywhere close to instilling and maintaining a sense of urgency,” he states. “We started off with basically a panic back in 2002 and had people really worked up. CWD was on the front pages for weeks and months."

While there is no evidence that CWD has spread to humans, Durkin says the infection rate in the state's deer herd has gone up every year for the past decade, and more should be done to encourage hunters to have the deer they harvest tested for the disease.

The DNR says the present method of voluntary testing is adequate.

Durkin disagrees, pointing out that the DNR didn't even mention voluntary CWD testing until the 33rd page of this year's deer hunting regulations. He maintains that's not the way to approach what he calls a very serious issue.

"Almost acting like it's no big deal, don't worry about it, if it's convenient drop your deer off, but there's no big push to get your deer tested,” he states. “And yet at the same time they're telling people that you shouldn't be eating deer from those areas unless they've been tested first, but they're telling people that in a real low-key manner."

Michigan, Missouri, Colorado and Wyoming – other states where deer hunting is popular – are taking a much more stringent approach to testing for CWD.

Durkin says right now CWD is not a threat to humans, but that could change.

"The thing is, though, give it time and diseases tend to adapt and change,” he points out. “And so even though right now we shouldn't be scared, I think down the road it might be. And so I think precaution is wise."





get more stories like this via email

After more than 50 years of use, some Michigan lawmakers say naloxone may not be the best choice in an overdose situation.

Naloxone is sometimes called the "Lazarus drug" because of its powerful ability to seemingly resurrect people after a drug overdose.

Sen. Kevin Hertel, D-St. Clair Shores, and some of his colleagues have introduced a bill which would open the door for what they say are more costly, but more powerful, antidotes.

"Given the prevalence of fentanyl in our communities, and how much stronger some of these drugs that we're now seeing are, we believe -- and in talking with others -- that there should be other tools to respond to an overdose," Hertel explained. "To make sure we're doing everything we can to save somebody's life."

Not everyone is on board with the proposed legislation, Senate Bill 542. Opponents argued the more expensive naloxone alternatives are not necessary, and using them would only increase profits for the pharmaceutical industry.

Jonathan Stoltman, director of the Opioid Policy Institute in Grand Rapids, said while the naloxone alternatives do help in overdose situations, they can also cause nasty side effects.

"The newer approaches, they put people into more severe withdrawal," Stoltman pointed out. "That's a pretty profound negative side effect. The one approach is very inexpensive and works great; the other approach is far more expensive and has this strong negative side effect."

Sponsors of the bill say they're hoping to give Michigan residents a chance to chime in on the issue in a public hearing sometime in June. Michigan saw more than 3,000 opioid overdose deaths in 2021.


get more stories like this via email

New Mexico saw record enrollment numbers for the Affordable Care Act this year and is now setting its sights on lowering out-of-pocket costs - those not reimbursed by insurance. More than 56,000 New Mexicans are enrolled in a medical health insurance plan on the state exchange - an increase of 12,000 people overall.

Colin Baillio, deputy superintendent with the state's Office of Insurance, said the state has boosted its outreach and made efforts to improve the overall consumer experience.

"We saw a 40% year-over-year increase, and New Mexico saw the biggest percentage increase during the open-enrollment period among all of the state-based marketplaces," he explained

Part of the enrollment increase is due to what's called the "unwinding" - a federal directive that required all states to redetermine Medicaid eligibility following a three-year pause on checks during the COVID pandemic. He said by using expanded tools made available by the federal and state government, 8% of New Mexico's population is now uninsured - down from 23% in 2010.

Following approval by lawmakers in the 2024 legislative session, the New Mexico governor signed seven health care-related bills into law - one of which requires annual reporting of prescription drug pricing. Baililo said the Affordable Care Act built the foundation that has allowed the state to pursue additional affordability initiatives.

"I'm really glad to see that there's so much interest in the next step of health reform, really leaning into these out-of-pocket cost issues and making it easier for people to afford to stay covered and see their doctors," he continued.

Two years ago, the state also passed a one-of-a-kind law that did away with behavioral health co-pays for people in certain insurance plans.

New York's medical aid-in-dying bill is gaining further support. The Medical Society of the State of New York is supporting the bill. New York's bill allows terminally ill people with only six months to live to use this option, with safeguards requiring two physicians' approval.

The bill's Assembly sponsor Amy Paulin, D-Westchester, said despite the growing support, other hurdles lie ahead.

"Now we have what I believe, if it came to the floor, a majority. There's still a hesitation on the part of leadership. You know, we need members to assure leadership that they no longer have reservations," she said.

Other newly resolved concerns center on making sure insurance companies and doctors who don't support this aren't held liable. She's optimistic the bill will pass after nine years in the Legislature. New York would be the 11th state along with Washington, D.C. to have medical aid in dying legislation.

Corinne Carey, senior New York campaign director with Compassion and Choices finds the pandemic drew a vivid picture of a person's end-of-life experience. There were images of people dying on ventilators, apart from loved ones, and unable to communicate. She said people began thinking about a "good death."

"And, what is a good death is being surrounded by loved ones, having some measure of control, experiencing the touch of your loved ones, and being the one in the driver's seat," she explained.

Now people have different options for end-of-life care, each of which presents various challenges. Polls show medical aid in dying has garnered considerable support since being introduced in 2015. A 2022 Compassion and Choices poll finds 57% of nurses support medical aid in dying professionally, although fewer support it personally.